GFBiochemicals is a sustainable chemicals company that produces levulinic acid derivatives at commercial scale directly from biomass. Having perfected its technology, product, and certification, the company is entering a new phase of commercialization.

Founded in 1972, Sofinnova Partners has backed more than 500 companies over 50 years, creating market leaders around the globe. Today, Sofinnova Partners has over €2.5 billion under management, focused on breakthrough innovations that have the potential to solve the world’s most pressing problems.

Matt Dixon, Peter Dixon, Roger Green, and Michelle Lynch advised GFBiochemicals on its fundraising options and strategy, made introductions, and coordinated the outreach process.

Mathieu Flamini, GFBiochemicals CEO, commented:

“GFBiochemicals is tackling one of the planet's most pressing and yet unrecognised challenges: how we make chemicals sustainable and non-harmful. Too many of our products are made with non-biodegradable, toxic chemicals, which cause environmental damage and affect people in their everyday life. We believe you cannot compromise on the planet and you should not compromise on performance. We hope to inspire and support others to accelerate their transition to green chemistry.

I enjoyed collaborating with CCD Partners, a team of very experienced and knowledgeable people." 

Guillaume Baxter, Sofinnova Partners, commented:

“There is a huge opportunity to transform the legacy chemicals industry and shift society away from its reliance on petrochemicals, Mathieu's team is at the start of an exciting new journey. With a great technological foundation and growing commercial traction, we're convinced they have what it takes to succeed."

Guillaume Sarlat, Sparta Capital, commented:

“Our current use of chemicals is not sustainable. The problem is so urgent that it is now a UN Sustainable Development goal to reduce deaths and illness from hazardous chemicals. We are backing Mathieu and his team because they have found a transformational alternative to address this problem. GFBiochemicals' innovative business approach is better for the planet and human health."

Selected information, quotes, and logos reproduced from the original press release found here - LINK